Move Past the STI: These 3 SGX Stocks Have Outperformed It by Over 100%

Trading Random
Yesterday

Singapore's Straits Times Index (SGX: ^STI) has been performing reasonably well. The SPDR STI ETF, which tracks the benchmark, delivered a solid 24% total return over the first eight months of 2026. However, three local mid-cap stocks have made that performance look almost underwhelming.

AEM Holdings delivered 411.3% in total returns over the same period. UMS Integration returned 133.9%, while First Resources came in at 130.1%. These are total returns, factoring in reinvested dividends rather than raw share price gains. All three sit at operational inflection points, backed by rapid top-line growth. Crucially, two have also seen dramatic operational cash flow turnarounds. For dividend investors, one metric matters above all: free cash flow – the lifeblood of dividends.

What sparked AEM's earnings reversal?

AEM's 1H2026 results reflected a dramatic operational pivot. Revenue rose 29.9% year on year (YoY) to S$247.2 million, while net profit attributable to owners surged roughly tenfold to S$31.0 million (up from S$3.1 million in 1H2025). The heavy lifting came from its Test Cell Solutions (TCS) segment, where revenue jumped 52.5% to S$180.9 million. Demand was driven by high-density test deployments for advanced artificial intelligence (AI) and high-performance computing (HPC) chips, with a single fabless AI customer becoming the group's largest revenue source. A more favourable segment mix expanded overall gross margins from 25.4% to 33.1%.

Management signalled continued momentum by raising FY2026 revenue guidance to between S$630 million and S$680 million (up from S$550 million to S$600 million previously). The board rewarded shareholders with a tax-exempt interim dividend of S$0.024 per share, after passing on an interim payout last year. The catch? Free cash flow plummeted 94.7% to S$2.0 million. Management pointed to aggressive inventory build-up ahead of heavy second-half deliveries, alongside uncollected receivables from late-period sales. Balance sheet strength remains intact, however, with S$82.7 million in cash against S$26.1 million in debt, leaving a net cash buffer of S$56.6 million.

What's driving UMS's expansion?

UMS turned in a stellar set of numbers for 2Q2026, reporting revenue of S$87.1 million, a 29% jump YoY. Net profit surged even faster, soaring 89% to S$19.4 million. As usual, semiconductor manufacturing did the heavy lifting, generating S$75.5 million in sales for a 28% increase. Meanwhile, the smaller aerospace division made impressive strides, growing 59% to contribute S$8.6 million. Geographically, revenue from Malaysia and Korea shot up 50% and 347% respectively, driven by component production ramping up for a new major customer.

Crucially, cash flow swung back into healthy positive territory. UMS generated S$30.7 million in free cash flow, reversing the negative S$8.3 million from a year prior, and ended the quarter with S$38.6 million in net cash and zero bank debt. Management declared a second interim dividend of S$0.010 per share. While the headline per-share payout looks unchanged from last year, remember that UMS issued 177.6 million bonus shares back in January 2026. Because that same dividend rate now applies across a larger share count, the total cash returned to shareholders has actually expanded. Looking ahead, global semiconductor equipment sales are projected by industry body SEMI to grow 23.2% to a record US$165.9 billion in 2026, offering a solid tailwind for the business.

Is First Resources' momentum built to last?

First Resources delivered an equally eye-catching performance for 1H2026. Revenue rose 44.5% YoY to US$973.6 million, while net profit attributable to owners jumped 57.4% to US$234.9 million. However, investors need to look past the top-line numbers. The comparison is not entirely like-for-like because PT Austindo Nusantara Jaya was acquired in May 2025 and only contributed two months of results in 1H2025, compared to a full six months in the latest figures. If we strip out fair value changes on biological assets, underlying net profit grew a still-respectable 42.2% to US$216.2 million, supported by stronger sales volumes, healthier processing margins, and a gross margin expansion to 42.0%.

The cash flow generation was outstanding. Operating cash flow leapt to US$210.7 million from US$13.8 million, helping free cash flow flip from a negative US$84.7 million to a positive US$100.6 million. Shareholders are directly reaping the rewards, with the interim dividend nearly doubling to S$0.08 per share from S$0.045 previously. The balance sheet remains solid with US$229.2 million in total cash and a net gearing ratio of 0.40x, though investors should note that US$115.4 million of that cash is restricted under Indonesia's updated export rules. Going forward, management points to volatile crude oil prices, Middle East geopolitical tensions, and potential El Niño weather disruptions as key variables that could influence palm oil demand and yield.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10